Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2021-05-10 Declaration of Voting R…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 10 MAY 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 10 May 2021. It details the voting outcomes on a specific resolution related to a disposal mandate. The text references the EGM Notice and Circular but does not contain the full meeting materials or detailed financial reports. The document is relatively short (about 5000 characters) and serves to officially communicate the voting results rather than the full meeting content or financial data. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-10 English
MAJOR TRANSACTION DELAY IN DESPATCH OF THE CIRCULAR IN RELATION TO LIMITED PARTNERSHIP AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a delay in the despatch of a circular related to a major transaction (Limited Partnership Agreement). It references a previous announcement and explains the reason for the delay and the new expected despatch date. The document does not contain the actual circular or detailed financial data but is an update about the timing of a report (the circular). The length is short (2662 characters), and it is clearly an announcement about the delay in sending a report rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related capital changes. It is addressed to the Hong Kong Exchanges and Clearing Limited and dated for the month ended 30/04/2021. The content focuses exclusively on share capital movements and related securities information, with no financial performance data, earnings, management discussion, or audit information. This type of document is a regulatory filing reporting share capital changes and movements in securities, typically required by stock exchanges or regulators. It is not an annual or interim report, earnings release, or management report. It is not a proxy, AGM material, or voting result announcement. It is not a director dealing or insider transaction report. The document is a regulatory announcement of share capital movements and securities information, fitting best under the category of Regulatory Filings (RNS).
2021-05-06 English
CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF ASSETS
Capital/Financing Update Classification · 95% confidence The document is an announcement by RemeGen Co., Ltd. regarding a connected transaction related to the acquisition of assets, specifically research and development equipment and materials. It details the contracts, parties involved, consideration, and compliance with listing rules. The document is an announcement of a transaction rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but focuses on the transaction terms and regulatory compliance. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including asset acquisitions. The document length is 8665 characters, sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is CAP with high confidence.
2021-05-03 English
MAJOR TRANSACTION DELAY IN DESPATCH OF THE CIRCULAR IN RELATION TO SUPPLEMENTAL AGREEMENT TO SUBSCRIPTION OF 49% INTEREST IN THE CAYMAN FUND
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a delay in the despatch of a circular related to a major transaction (subscription of 49% interest in the Cayman Fund). It references a previous announcement and explains the reason for the delay and the new expected despatch date. The document is short (2611 characters) and does not contain any financial statements or detailed financial data. It is clearly an announcement about the timing of a circular related to a major transaction, not the transaction details themselves or a full report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about procedural matters related to a major transaction.
2021-05-03 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 April 2021
Major Shareholding Notification Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 30/4/2021. The content is focused on share capital changes and confirmations related to securities issued by the company. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory filing reporting monthly movements in securities and share capital, consistent with a Major Shareholding Notification or similar regulatory disclosure. Given the detailed share capital movement and confirmations, this fits best under the category Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or share capital movements. The document is not an announcement of a report, nor a full financial report, so it is not RPA or 10-K or IR. It is not a director dealing report or capital/financing update per se, but a regulatory filing of share capital movements. Therefore, the best classification is MRQ with high confidence.
2021-04-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.